{
  "ticker": "LLY",
  "target_date": "2025-05-14",
  "actual_date": "2025-05-14",
  "collected_at": "2025-12-08T11:45:54.218985",
  "price": {
    "open": 744.97,
    "high": 755.18,
    "low": 709.97,
    "close": 711.486328125,
    "volume": 7558500,
    "change_1d_pct": -4.09,
    "change_7d_pct": -12.89,
    "change_30d_pct": -11.14
  },
  "technicals": {
    "rsi_14": 28.88,
    "sma_20": 802.89,
    "sma_50": 804.4,
    "macd": -19.629,
    "macd_signal": -8.142,
    "macd_histogram": -11.487,
    "bb_upper": 915.82,
    "bb_lower": 689.97,
    "price_vs_sma20_pct": -11.38,
    "price_vs_sma50_pct": -11.55,
    "volume_ratio": 1.47
  },
  "fundamentals": {
    "market_cap": 892489957376,
    "pe_ratio": 48.778786,
    "forward_pe": 43.93535,
    "price_to_book": 37.484,
    "price_to_sales": 15.0197,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.47,
    "pct_from_52w_low": 59.6
  },
  "macro": {
    "spy": {
      "price": 584.24,
      "change_1d_pct": 0.13,
      "change_7d_pct": 5.15
    },
    "vix": {
      "level": 18.62,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.53
    },
    "dollar_index": {
      "level": 101.04
    },
    "gold": {
      "price": 3181.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "LLY Q1 Earnings Call: Revenue Beats Expectations, Profit Guidance Trimmed Amid Price Pressures",
      "source": "Yahoo",
      "datetime": 1747261919,
      "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Street\u2019s expectations in Q1 CY2025, with sales up 45.2% year on year to $12.73 billion. The company expects the full year\u2019s revenue to be around $59.5 billion, close to analysts\u2019 estimates. Its non-GAAP profit of $3.34",
      "url": "https://finnhub.io/api/news?id=6fab3abb5e2ceaa0a67c1ec720bf65466ed274c3fe5a86764c96a3cd50cc5926"
    },
    {
      "headline": "RFK Jr. Attacks Health Agency, Defends Cuts Before Congress",
      "source": "Yahoo",
      "datetime": 1747258184,
      "summary": "(Bloomberg) -- Health and Human Services Secretary Robert F. Kennedy Jr. defended cutting thousands of staff and attacked the agency\u2019s past work in his first day appearing before Congress since taking the nation\u2019s top health role.Most Read from BloombergAs Coastline Erodes, One California City Consi",
      "url": "https://finnhub.io/api/news?id=fd12a24476958d9b70358ba3bb1ffef31076954719a05a3d2528a9c6d89fd2df"
    },
    {
      "headline": "Eli Lilly Shares Tumble After Rival Novo?Nordisk Strikes Major Weight Loss Deal",
      "source": "Yahoo",
      "datetime": 1747257626,
      "summary": "Lilly Pullback Follows $2.2B Obesity Licensing Deal by Novo?Nordisk",
      "url": "https://finnhub.io/api/news?id=cbecd10825f848378dc133a2db5ed91d6725055745ed4e0bece292178effabbc"
    },
    {
      "headline": "Healthcare worst-performing S&P 500 subsector year to date: Mizuho expert",
      "source": "Yahoo",
      "datetime": 1747238373,
      "summary": "Tariffs, executive orders, and FTC probes are just some of the problems piling up for the pharmaceutical industry. Trump's actions are pressuring a historically \"safe\" sector.",
      "url": "https://finnhub.io/api/news?id=4cb69af4c2b40b9be1f2c907518b3daa766aee160dfc1a2e708c1300eaafcce8"
    },
    {
      "headline": "BlackRock Health Sciences Opportunities Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1747237080,
      "summary": "BlackRock Health Sciences Opportunities Fund posted returns of 3.66% (Institutional shares) and 3.60% (Investor A shares, without sales charge) for the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=a09fa1031198fe3423a5318e0d47459c521efb03ae4196a089069f85176f0e54"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-05-08",
      "description": "lly-20250505.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000138/lly-20250505.htm"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746476222.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000134/xslF345X05/wk-form4_1746476222.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-05-01",
      "description": "lly-20250331.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/lly-20250331.htm"
    },
    {
      "form": "8-K",
      "date": "2025-05-01",
      "description": "lly-20250501.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/lly-20250501.htm"
    },
    {
      "form": "4",
      "date": "2025-04-22",
      "description": "xslF345X05/wk-form4_1745353361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}